# Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM

> **NCT04746456** · — · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 210 (actual)

## Conditions studied

- Vulvovaginal Atrophy
- Menopause
- Genitourinary Syndrome of Menopause

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04746456
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746456, "Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel PROM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04746456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*